SEC 13F Intelligence

Trv GP IV, LLC / PLRX

Trv GP IV, LLC’s Pliant Therapeutics Inc Position

Does Trv GP IV, LLC own Pliant Therapeutics Inc (PLRX)? Not currently — the last reported position was 2.13M shares worth $2M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2025
Shares
2.13M
% of Portfolio
+1.51%
Quarters Held
21
position exited

Position History PLRX

Reported value by quarter
Q2 ’20: $69MQ2 ’20Q3 ’20: $48MQ4 ’20: $48MQ1 ’21: $84MQ1 ’21Q2 ’21: $62MQ3 ’21: $36MQ4 ’21: $29MQ4 ’21Q1 ’22: $15MQ2 ’22: $17MQ3 ’22: $45MQ3 ’22Q4 ’22: $41MQ1 ’23: $57MQ2 ’23: $39MQ2 ’23Q3 ’23: $37MQ4 ’23: $39MQ1 ’24: $32MQ1 ’24Q2 ’24: $23MQ3 ’24: $24MQ4 ’24: $28MQ4 ’24Q1 ’25: $3MQ2 ’25: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20252.13M$2M+1.51%
Q1 20252.13M$3M+3.10%
Q4 20242.13M$28M+35.03%
Q3 20242.13M$24M+14.75%
Q2 20242.13M$23M+11.34%
Q1 20242.13M$32M+15.40%
Q4 20232.13M$39M+15.69%
Q3 20232.13M$37M+13.93%
Q2 20232.13M$39M+34.92%
Q1 20232.13M$57M+40.55%
Q4 20222.13M$41M+17.53%
Q3 20222.13M$45M+26.03%
Q2 20222.13M$17M+11.23%
Q1 20222.13M$15M+5.48%
Q4 20212.13M$29M+8.28%
Q3 20212.13M$36M+8.17%
Q2 20212.13M$62M+29.57%
Q1 20212.13M$84M+30.90%
Q4 20202.13M$48M+15.55%
Q3 20202.13M$48M+16.63%
Q2 20202.13M$69M+31.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP IV, LLC’s full portfolio or all institutional holders of PLRX.